Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Bone Marrow Transplantation|February 3, 2004
Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantationF Patriarca, C Skert, A Sperotto, et al.Bone Marrow Transplantation|March 7, 1998
Autologous stem cell transplantation for aggressive non-Hodgkin's lymphomas in first complete or partial remission: a retrospective analysis of the outcome of 52 patients according to the age-adjusted International Prognostic IndexR Fanin, F Silvestri, A Geromin, et al.Leukemia & Lymphoma|January 1, 1997
Sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)--positive anaplastic large cell lymphoma in adultsR Fanin, F Silvestri, A Geromin, et al.Haematologica|November 1, 1996
The F-MACHOP regimen in the treatment of aggressive non-Hodgkin's lymphomas: a single center experience in 72 patientsL Infanti, F Silvestri, R Fanin, et al.Leukemia & Lymphoma|October 8, 1999
The therapy of primary adult systemic CD30-positive anaplastic large cell lymphoma: results of 40 cases treated in a single centerR Fanin, A Sperotto, F Silvestri, et al.Bone Marrow Transplantation|October 12, 1999
Autologous bone marrow transplantation in non-Hodgkin's lymphoma patients: effect of a brief course of G-CSF on harvest and recoveryD Damiani, S Grimaz, L Infanti, et al.Blood|February 15, 1996
Primary systemic CD30 (Ki-1)-positive anaplastic large cell lymphoma of the adult: sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous bone marrow transplantationR Fanin, F Silvestri, A Geromin, et al.Haematologica|September 12, 2000
A retrospective analysis of 144 patients with aggressive non-Hodgkin's lymphoma: impact of autologous stem cell transplantation in first remission on outcomeR Fanin, A Sperotto, C Ruiz De Elvira, et al.Haematologica|May 21, 1998
P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemiasD Damiani, M Michieli, A Ermacora, et al.Blood|July 1, 1997
Randomized trial of autologous filgrastim-primed bone marrow transplantation versus filgrastim-mobilized peripheral blood stem cell transplantation in lymphoma patientsD Damiani, R Fanin, F Silvestri, et al.Pageof 4